Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Interest Income - Net (2021 - 2025)

Abeona Therapeutics (ABEO) has 5 years of Interest Income - Net data on record, last reported at $771000.0 in Q3 2025.

  • For Q3 2025, Interest Income - Net rose 786.21% year-over-year to $771000.0; the TTM value through Sep 2025 reached $1.1 million, up 49.66%, while the annual FY2024 figure was $38000.0, 97.76% down from the prior year.
  • Interest Income - Net reached $771000.0 in Q3 2025 per ABEO's latest filing, up from $70000.0 in the prior quarter.
  • Across five years, Interest Income - Net topped out at $771000.0 in Q3 2025 and bottomed at -$676000.0 in Q3 2021.
  • Average Interest Income - Net over 5 years is $112000.0, with a median of $103000.0 recorded in 2024.
  • Peak YoY movement for Interest Income - Net: plummeted 141.44% in 2024, then soared 786.21% in 2025.
  • A 5-year view of Interest Income - Net shows it stood at -$676000.0 in 2021, then skyrocketed by 122.19% to $150000.0 in 2022, then surged by 322.67% to $634000.0 in 2023, then crashed by 109.31% to -$59000.0 in 2024, then soared by 1406.78% to $771000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Income - Net were $771000.0 in Q3 2025, $70000.0 in Q2 2025, and $312000.0 in Q1 2025.